Epidemiology of hepatitis C infection among pregnant women and parturients in Nizhny Novgorod

Hepatitis C is an urgent global health problem. The high prevalence of infection among the population leads to the involvement of women of reproductive age in the epidemic process. In order to study the prevalence of specific markers of hepatitis C virus in pregnant women and to assess the risk of intrauterine infection of the fetus, an epidemiologic analysis was conducted using information collections of statistical and analytical materials of Rospotrebnadzor, blood serum samples of pregnant and postpartum women (n = 28394) at admission to obstetric institutions for the period 2018–2022 were examined. According to statistical reporting, the average annual prevalence of anti-HCV prevalence in pregnant women was 1.7% (95% CI: 1.5–1.9%). Women aged 40–49 years were found to be most actively involved in the epidemic process (4.3% [95% CI: 3.3–5.6%]). Among anti-HCV-positive samples, HCV RNA was detected in 47.0% (95% CI: 41.7–52.9%) of cases, the prevalence of current infection confirmed by HCV RNA detection in pregnant women was 0.9% (95% CI: 0.8–1.0%). The pattern of HCV genotypes in pregnant women was as follows: subtype 1b was detected in 34.9% (95% CI: 25.6–45.7%) of cases, subtype 3a in 42.2% (95% DI: 32.1–52.9%), minor subtype 1a was 9.6% (95% CI: 5.0–17.9%) and genotype 2 was 7.0% (95% CI: 3.4–14.9%). Samples containing two genotypes simultaneously (1a/1b, 1b/3a) were 3.6% (95% CI: 1.2–10.1%) and non-genotyped samples were 2.4% (95% CI: 0.7–4.1%). The results of the assessment of the significance of risk factors for perinatal transmission of hepatitis C virus show a high degree of influence on vertical transmission of HCV RNA in the presence of active infection in the mother (RR = 6.4; [95% CI: 0.9–44.6%]: p < 0.05), no statistical significance of HCV genotypic affiliation (p > 0.05) and maternal viral load level (R = 0.00009; p > 0.05). The obtained data argue the necessity of screening examinations for molecular genetic markers of hepatitis C virus in women planning pregnancy in order to conduct antiviral therapy and, as a consequence, to reduce the risk of perinatal infection of children.

1. Pott H., Theodoro M., de Almeida Vespoli J., Senise J.F., Castelo A. Mother-to-child transmission of hepatitis C virus. Eur J Obstet Gynecol Reprod Biol. 2018; 224: 125–130. https://doi:10.1016/j.ejogrb.2018.03.034

2. Мозес К.Б., Мозес В. Г., Захаров И.С., Елгина С.И., Рудаева Е.В. Гепатит С при беременности – современные подходы к скринингу, лечению и профилактике осложнений. Мать и дитя в Кузбассе. 2019; 3 (78): 4–9. Mozes K.B., Mozes V.G., Zaharov I.S., Elgina S.I., Rudaeva E.V. Hepatitis C in pregnancy – modern approaches to screening, treatment and prevention of complications. Mothe and Child (In Russ). 2019; 3 (78): 4–9.

3. Agyeman A.A., Ofori-Asenso R., Mprah A., Ashiagbor G. Epidemiology of hepatitis C virus in Ghana: A systematic review and meta-analysis. BMC Infect Dis. 2016; 16 (1). https://doi:10.1186/s12879–016–1708–7

4. Floreani A. Hepatitis C and pregnancy. World J Gastroenterol. 2013; 19 (40): 6714–6720. https://doi:10.3748/wjg.v19.i40.6714

5. Eleje G.U., Onubogu C.U., Fiebai P.O., et al. Mother-to-child transmission of human immunodeficiency virus., hepatitis B virus and hepatitis C virus among pregnant women with single., dual or triplex infections of human immunodeficiency virus., hepatitis B virus and hepatitis C virus in Nigeria. SAGE Open Med. 2022; 10. https://doi:10.1177/20503121221095411

6. Ruiz-Extremera Á., del Mar Díaz-Alcázar M., Muñoz-Gámez J.A., et al. Seroprevalence and epidemiology of hepatitis B and C viruses in pregnant women in Spain. Risk factors for vertical transmission. PLoS One. 2020; 15 (5): 1–13. https://doi:10.1371/journal.pone.0233528

7. Хоронжевская И.С., Мартынюк Г.А., Шевченко Г.Н., et al. Современная эпидемиологическая и вирусологическая характеристика гепатита С на территории северо-западной части Украины. Эпидемиология и вакцинопрофилактика. 2011; 6 (61): 50–55. Horonzhevskaja I.S., Martynjuk G.A., Shevchenko G.N. et al. The Modern Epidemiological and Virologic Characteristic of the Hepatites C in Territory of North-west Part of Ukraine. Epidemiology and Vaccinal Prevention (In Russ). 2011; 6 (61): 50–55.

8. Prasad M., Saade G.R., Sandoval G., et al. Hepatitis C Virus Antibody Screening in a Cohort of Pregnant Women: Identifying Seroprevalence and Risk Factors. Physiol Behav. 2020; 135 (4): 778–788. https://doi: https://doi:10.1097/aog.0000000000003754

9. Luetkemeyer A.F., Wyles D.L. Hepatitis C Virus Care Cascade. CROI 2019 Highlights Viral Hepat. 2019; 27 (1). http://www.croiwebcasts.org/?

10. Watts T., Stockman L., Martin J., Guilfoyle S., Vergeront J.M. Increased Risk for Mother-to-Infant Transmission of Hepatitis C Virus Among Medicaid Recipients – Wisconsin, 2011–2015. MMWR Morb Mortal Wkly Rep. 2017; 66 (42): 1136–1139. https://doi:10.15585/mmwr.mm6642a3

11. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing., Managing., and Treating Hepatitis C Virus Infection. Clin Infect Dis an Off Publ Infect Dis Soc Am. 2018; 67 (10): 1477–1492. https://doi:10.1093/cid/ciy585

12. Ершова О.Н., Шахгильдян И.В., Коленова Т.В., Кузин С.Н., Самохвалов., Е.И.., Кириллова ИЛ., Розова AВ. Естественные пути передачи вируса гепатита С – современный взгляд на проблему. Детские инфекции. 2006; 1: 16–18. Ershova O.N., Shakhgildyan I.V., Kolenova T.V., Kuzin S.N., Samokhvalov., E.I., Kirillova IL., Rozova AV. Natural ways of transmission of hepatitis C virus – a modern view of the problem. Children Infections (In Russ). 2006; 1: 16–18.

13. Федосеева Л.Р., Алексеева М.Н., Именева В.И., Самсонова В.К., Иванова ЕД. Клинические особенности вирусных гепатитов у беременных в республике Саха (Якутия). Фундаментальные исследования. 2004; 2: 101–102. Fedoseeva L.R., Alekseeva M.N., Imeneva V.I., Samsonova V.K., Ivanova ED. Clinical features of viral hepatitis in pregnant women in the Republic of Sakha (Yakutia). Fundamental Research (In Russ). 2004; 2: 101–102.

14. Ситник Т.Н., Чемодурова Ю.В., Мамчик Т.А., Мамчик Н.П., Мацаева Э.А. Распространенность маркеров вирусных гепатитов В и С у отдельных контингентов в Воронежской области. Профилактическая и клиническая медицина. 2017; 3 (64): 21–25. Sitnik T.N., Chemodurova Y. V., Mamchik T.A., Mamchik N.P., Mazaeva E.A. Prevalence of markers of viral hepatitis B and C in individual contingents in the Voronezh Region. Preventive and Clinical Medicine (In Russ). 2017; 3 (64): 21–25.

15. Ковалева Т.А., Чуйкова К.И., Алексеева Е.А. Эпидемиологическая характеристика хронических гепатитов В и С у беременных женщин на территории Томской области. Эпидемиология и вакцинопрофилактика. 2011; 3 (58): 38–41. Kovaleva T.A., Chuikova K.I., Alekseeva E.A. Epidemiological Characteristics of Chronic Hepatitis B and C in Pregnant Women in Tomsk Region. Epidemiology and Vaccinal Prevention (In Russ). 2011; 3 (58): 38–41.

16. Матейкович Е.А., Кукарская И.И., Легалова Т.В. Клинико-статистическая оценка репродуктивного здоровья женщин фертильного возраста Тюменской области и риски невынашивания беременности в условиях Западной Сибири. Медицинский совет. 2021 (21–1): 198–204. https://doi:10.21518/2079–701x‑2021–21–1–198–204 Mateykovich Е. А., Kukarskaya I. I., Legalova T. V. Clinical and statistical assessment of the reproductive health of fertilized women in the Tyumen region and the risks of miscarriage in Western Siberia. Medical Council. (In Russ). 2021 (21–1): 198–204. https://doi:10.21518/2079–701X‑2021–21–1–198–204

17. Якимова А.В., Мухамедшина В.Р., Кучеренко С. Г. Вирусный гепатит С при беременности: распространенность, влияние на перинатальные исходы, тактика ведения пациентов (обзор литературы). Consilium Medicum. 2022; 24 (7): 477–480. https://doi:10.26442/20751753.2022.7.201799 Yakimova A.V., Mukhamedshina V.R., Kucherenko S.G. Viral hepatitis C during pregnancy: Prevalence, impact on perinatal outcomes, patient management tactics (literature review). Consilium Medicum (In Russ). 2022 24 (7): 477–480. https://doi:10.26442/20751753.2022.7.201799

18. Михайлова Ю.В., Быстрова Т.Н., Сутырина О.М. Молекулярно-эпидемиологическая характеристика гепатита С в группах высокого риска инфицирования лечебно-профилактических учреждений Нижнего Новгорода. Медицинский альманах. 2015; 5: 54–60. Mikhailova Y.V., Bystrova T.N., Sutyrina O.M. Molecular and epidemiological characteristics of hepatitis C in high-risk groups of infection in medical and preventive institutions of Nizhny Novgorod. Medical Almanac (In Russ). 2015; 5: 54–60.

19. Кашникова А.Д., Быстрова Т.Н., Полянина А.В., Залесских А.А. Молекулярно-генетический мониторинг как компонент эпидемиологического надзора за гепатитом С. Здоровье населения и среда обитания. 2022; 30 (11): 76–81. https://doi:10.35627/2219–5238/2022–30–11–76–81 Kashnikova A.D., Bystrova T.N., Polyanina A.V., Zalesskikh A.A. Genetic Monitoring as a Component of Hepatitis C Surveillance. Population health and Habitat (In Russ). 2022; 30 (11): 76–81. https://doi:10.35627/2219–5238/2022–30–11–76–81

20. Deng S., Zhong W., Chen W., Wang Z. Hepatitis C viral load and mother-to-child transmission: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2023; 38 (2): 177–186. https://doi:10.1111/jgh.15998